首页 > 最新文献

Khirurgiya最新文献

英文 中文
[Modern possibilities for transcatheter pulmonary valve replacement]. [经导管肺动脉瓣置换术的现代可能性]。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/hirurgia202402132
S N Manukyan, I A Soynov, A V Voytov, K A Rzaeva, A A Baranov, A V Bogachev-Prokofiev

The literature review is devoted to transcatheter pulmonary valve replacement. The authors summarize the indications, clinical data and current capabilities of transcatheter pulmonary valve replacement. The authors also overviewed modern valves for transcatheter pulmonary artery replacement. Effectiveness of transcatheter pulmonary valve implantation has been substantiated. Various studies comparing the outcomes of different valve systems for endovascular implantation were analyzed. The authors concluded the prospects for transcatheter pulmonary valve implantation.

这篇文献综述专门讨论经导管肺动脉瓣置换术。作者总结了经导管肺动脉瓣置换术的适应症、临床数据和目前的能力。作者还概述了用于经导管肺动脉置换的现代瓣膜。经导管肺动脉瓣植入术的有效性已得到证实。作者分析了比较不同瓣膜系统在血管内植入效果的各种研究。作者总结了经导管肺动脉瓣植入术的前景。
{"title":"[Modern possibilities for transcatheter pulmonary valve replacement].","authors":"S N Manukyan, I A Soynov, A V Voytov, K A Rzaeva, A A Baranov, A V Bogachev-Prokofiev","doi":"10.17116/hirurgia202402132","DOIUrl":"10.17116/hirurgia202402132","url":null,"abstract":"<p><p>The literature review is devoted to transcatheter pulmonary valve replacement. The authors summarize the indications, clinical data and current capabilities of transcatheter pulmonary valve replacement. The authors also overviewed modern valves for transcatheter pulmonary artery replacement. Effectiveness of transcatheter pulmonary valve implantation has been substantiated. Various studies comparing the outcomes of different valve systems for endovascular implantation were analyzed. The authors concluded the prospects for transcatheter pulmonary valve implantation.</p>","PeriodicalId":35986,"journal":{"name":"Khirurgiya","volume":" 2","pages":"32-44"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139724312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Surgery for mediastinal teratoma containing pancreatic tissue]. [含有胰腺组织的纵隔畸胎瘤手术]。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/hirurgia202402175
V D Parshin, A V Parshin, M A Ursov, N B Paramonova, A S Tertychnyy, V O Dzhuganova

Surgery for mediastinal tumors is still one of the most difficult in modern medicine. This is due to vital organs and various nature of tumors in this area. Teratomas are relatively rare among mediastinal tumors. However, they have certain features that is important for treatment strategy and management of possible complications. This can complicate diagnostic algorithm, exclude transthoracic biopsy and contribute to active surgical approach even for benign process. Oncogenesis of teratoma has its own characteristics. Tissues of different organs are always present in this tumor. Among these, pancreatic tissue inclusions are rare. A few data in the world literature on the treatment of such patients do not allow to develop a universally accepted algorithm of diagnosis and treatment. The authors present two patients with mediastinal teratoma. The second patient had teratoma with pancreatic tissue. The authors discuss the diagnostic algorithm for similar cases. A special attention is paid to description of possible complications throughout long-term follow-up period. Surgical aspects including the choice of access and local spread of process (adhesions in the area of surgical interest) are considered. The report on the treatment of two patients with rare mediastinal tumors containing pancreatic tissue will be useful for primary care physicians, thoracic surgeons, oncologists and morphologists.

纵隔肿瘤手术仍然是现代医学中最困难的手术之一。这是因为该区域有重要的器官,而且肿瘤的性质多种多样。在纵隔肿瘤中,畸胎瘤相对罕见。然而,它们具有某些特征,这对治疗策略和处理可能出现的并发症非常重要。畸胎瘤是一种良性肿瘤,它可能使诊断算法复杂化,排除经胸活检,即使是良性肿瘤也需要积极的手术治疗。畸胎瘤的肿瘤发生有其自身的特点。这种肿瘤中总是存在不同器官的组织。其中,胰腺组织内含物很少见。世界文献中有关此类患者治疗的数据很少,因此无法制定普遍接受的诊断和治疗算法。作者介绍了两名纵隔畸胎瘤患者。第二名患者的畸胎瘤带有胰腺组织。作者讨论了类似病例的诊断算法。作者还特别关注了长期随访期间可能出现的并发症。作者还考虑了手术方面的问题,包括入路的选择和手术过程的局部扩散(手术区域的粘连)。这篇关于两名患有含有胰腺组织的罕见纵隔肿瘤患者的治疗报告将对初级保健医生、胸外科医生、肿瘤学家和形态学专家有所帮助。
{"title":"[Surgery for mediastinal teratoma containing pancreatic tissue].","authors":"V D Parshin, A V Parshin, M A Ursov, N B Paramonova, A S Tertychnyy, V O Dzhuganova","doi":"10.17116/hirurgia202402175","DOIUrl":"10.17116/hirurgia202402175","url":null,"abstract":"<p><p>Surgery for mediastinal tumors is still one of the most difficult in modern medicine. This is due to vital organs and various nature of tumors in this area. Teratomas are relatively rare among mediastinal tumors. However, they have certain features that is important for treatment strategy and management of possible complications. This can complicate diagnostic algorithm, exclude transthoracic biopsy and contribute to active surgical approach even for benign process. Oncogenesis of teratoma has its own characteristics. Tissues of different organs are always present in this tumor. Among these, pancreatic tissue inclusions are rare. A few data in the world literature on the treatment of such patients do not allow to develop a universally accepted algorithm of diagnosis and treatment. The authors present two patients with mediastinal teratoma. The second patient had teratoma with pancreatic tissue. The authors discuss the diagnostic algorithm for similar cases. A special attention is paid to description of possible complications throughout long-term follow-up period. Surgical aspects including the choice of access and local spread of process (adhesions in the area of surgical interest) are considered. The report on the treatment of two patients with rare mediastinal tumors containing pancreatic tissue will be useful for primary care physicians, thoracic surgeons, oncologists and morphologists.</p>","PeriodicalId":35986,"journal":{"name":"Khirurgiya","volume":" 2","pages":"75-83"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139724325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Advisability of carotid endarterectomy in asymptomatic patients]. [无症状患者颈动脉内膜切除术的可取性]。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/hirurgia202403145
D A Korshunov, V A Kulbak, A V Chupin

Objective: To determine the optimal treatment strategy for patients with asymptomatic carotid stenosis.

Material and methods: The authors reviewed clinical guidelines for the management of patients with asymptomatic carotid stenosis 60-99%, as well as medical studies and meta-analyses comparing carotid endarterectomy and optimal drug therapy in asymptomatic patients between 1993 and 2023.

Results: The choice of treatment strategy for patients with asymptomatic carotid artery stenosis is still a controversial issue. There were several large randomized clinical trials comparing carotid endarterectomy with optimal medical therapy in asymptomatic patients at the end of the 20th century. However, drug therapy has undergone significant changes calling into question the relevance of previous results. This review highlights the evolution of management of patients with asymptomatic carotid stenosis and also presents modern approaches to the treatment of these patients.

Conclusion: Patients younger 75 years old gain an advantage from carotid endarterectomy with small perioperative risk compared to optimal drug therapy and yearly risk of cerebral embolism. Patients with asymptomatic carotid stenosis 80-99% are candidates for carotid endarterectomy due to higher risk of acute cerebrovascular accident at least until more data are available. The choice of the best tactics for a particular patient should be made individually depending on own experience and patient's adherence to therapy and lifestyle correction. The results of the ACTRIS (2025) and CREST-2 (2026) studies are expected to clarify this issue.

目的:确定无症状颈动脉狭窄患者的最佳治疗策略:确定无症状颈动脉狭窄患者的最佳治疗策略:作者回顾了1993年至2023年间关于无症状颈动脉狭窄60%-99%患者治疗的临床指南,以及比较无症状患者颈动脉内膜剥脱术和最佳药物治疗的医学研究和荟萃分析:无症状颈动脉狭窄患者治疗策略的选择仍存在争议。20 世纪末,有几项大型随机临床试验对无症状患者的颈动脉内膜切除术和最佳药物疗法进行了比较。然而,药物治疗已经发生了重大变化,这使人们对之前结果的相关性产生了质疑。本综述重点介绍了无症状颈动脉狭窄患者的治疗演变,并介绍了治疗这些患者的现代方法:结论:与最佳药物治疗和每年的脑栓塞风险相比,75 岁以下的患者可从颈动脉内膜切除术中获益,但围术期风险较小。无症状颈动脉狭窄80%-99%的患者由于急性脑血管意外的风险较高,至少在获得更多数据之前,可以选择颈动脉内膜剥脱术。应根据自身经验、患者对治疗的依从性和生活方式的纠正,为特定患者选择最佳策略。ACTRIS(2025年)和CREST-2(2026年)研究的结果有望澄清这一问题。
{"title":"[Advisability of carotid endarterectomy in asymptomatic patients].","authors":"D A Korshunov, V A Kulbak, A V Chupin","doi":"10.17116/hirurgia202403145","DOIUrl":"10.17116/hirurgia202403145","url":null,"abstract":"<p><strong>Objective: </strong>To determine the optimal treatment strategy for patients with asymptomatic carotid stenosis.</p><p><strong>Material and methods: </strong>The authors reviewed clinical guidelines for the management of patients with asymptomatic carotid stenosis 60-99%, as well as medical studies and meta-analyses comparing carotid endarterectomy and optimal drug therapy in asymptomatic patients between 1993 and 2023.</p><p><strong>Results: </strong>The choice of treatment strategy for patients with asymptomatic carotid artery stenosis is still a controversial issue. There were several large randomized clinical trials comparing carotid endarterectomy with optimal medical therapy in asymptomatic patients at the end of the 20<sup>th</sup> century. However, drug therapy has undergone significant changes calling into question the relevance of previous results. This review highlights the evolution of management of patients with asymptomatic carotid stenosis and also presents modern approaches to the treatment of these patients.</p><p><strong>Conclusion: </strong>Patients younger 75 years old gain an advantage from carotid endarterectomy with small perioperative risk compared to optimal drug therapy and yearly risk of cerebral embolism. Patients with asymptomatic carotid stenosis 80-99% are candidates for carotid endarterectomy due to higher risk of acute cerebrovascular accident at least until more data are available. The choice of the best tactics for a particular patient should be made individually depending on own experience and patient's adherence to therapy and lifestyle correction. The results of the ACTRIS (2025) and CREST-2 (2026) studies are expected to clarify this issue.</p>","PeriodicalId":35986,"journal":{"name":"Khirurgiya","volume":" 3","pages":"45-53"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140111733","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Da Vinci robotic complex in hernia repair surgery]. [达芬奇机器人在疝修补手术中的应用]。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/hirurgia202403114
A V Kolygin, M I Vyborny, D I Petrov

Objective: To review the first robotic hernia repairs performed at the Ilyinsky Hospital, evolution of this technology, learning curve and early outcomes.

Material and methods: There were 17 procedures at the Ilyinskaya Hospital between 2021 and 2023 (13 men and 4 women). Mean age was 60 years, body mass index 28 kg/m2. ASA grade 1 was observed in 1 patient, grade 2 - 14 ones, grade 3 - 2 patients. Ventral, inguinal and umbilical hernias were diagnosed in 7, 8 and 2 cases, respectively. Ventral hernias required IPOM+ procedure in 3 cases, eTEP-RS procedure in 2 cases and eTEP-RS-TAR procedure in 2 cases. Patients with inguinal hernia underwent transabdominal preperitoneal hernia repair. In case of umbilical hernia, TARUP procedure was performed in 1 case and vTAPP procedure in 1 case.

Results: Mean surgery time was 2 hours 38 min (min 1 hour 35 min, max 10 hours 11 min). There was one intraoperative complication (bleeding from epigastric artery). The follow-up period ranged from 3 months to 3 years. There were no recurrent hernias. Postoperative complications were noted in 2 cases. One patient was diagnosed with epididymitis after TAPP, 1 patient - with seroma after eTEP-RS procedure. All complications were relieved by conservative treatment. Bleeding from a. epigastrica inferior was diagnosed after removal of the trocar at the end of surgery. This event required suturing.

Conclusion: Robotic hernia repair appears to be technically feasible and safe. This approach provides favorable results regarding quality of life and recurrence rate.

摘要回顾伊林斯基医院首次进行的机器人疝修补术、该技术的发展、学习曲线和早期结果:2021年至2023年期间,伊林斯基医院共进行了17例手术(13名男性和4名女性)。平均年龄为 60 岁,体重指数为 28 kg/m2。1名患者为ASA 1级,14名患者为2级,2名患者为3级。诊断出腹股沟疝、腹股沟疝和脐疝的病例分别为 7 例、8 例和 2 例。3例腹股沟疝患者需要进行IPOM+手术,2例需要进行eTEP-RS手术,2例需要进行eTEP-RS-TAR手术。腹股沟疝患者接受了经腹腹膜前疝修补术。脐疝患者中,1 例采用 TARUP 手术,1 例采用 vTAPP 手术:平均手术时间为 2 小时 38 分钟(最短 1 小时 35 分钟,最长 10 小时 11 分钟)。术中发生一起并发症(上腹部动脉出血)。随访时间从 3 个月到 3 年不等。没有疝气复发。有 2 例患者出现术后并发症。一名患者在 TAPP 术后被诊断为附睾炎,一名患者在 eTEP-RS 术后被诊断为血清肿。所有并发症均通过保守治疗得到缓解。手术结束拔出套管后,诊断出附睾下端出血。结论结论:机器人疝修补术在技术上可行且安全。结论:机器人疝修补术在技术上可行且安全,在生活质量和复发率方面效果良好。
{"title":"[Da Vinci robotic complex in hernia repair surgery].","authors":"A V Kolygin, M I Vyborny, D I Petrov","doi":"10.17116/hirurgia202403114","DOIUrl":"10.17116/hirurgia202403114","url":null,"abstract":"<p><strong>Objective: </strong>To review the first robotic hernia repairs performed at the Ilyinsky Hospital, evolution of this technology, learning curve and early outcomes.</p><p><strong>Material and methods: </strong>There were 17 procedures at the Ilyinskaya Hospital between 2021 and 2023 (13 men and 4 women). Mean age was 60 years, body mass index 28 kg/m<sup>2</sup>. ASA grade 1 was observed in 1 patient, grade 2 - 14 ones, grade 3 - 2 patients. Ventral, inguinal and umbilical hernias were diagnosed in 7, 8 and 2 cases, respectively. Ventral hernias required IPOM+ procedure in 3 cases, eTEP-RS procedure in 2 cases and eTEP-RS-TAR procedure in 2 cases. Patients with inguinal hernia underwent transabdominal preperitoneal hernia repair. In case of umbilical hernia, TARUP procedure was performed in 1 case and vTAPP procedure in 1 case.</p><p><strong>Results: </strong>Mean surgery time was 2 hours 38 min (min 1 hour 35 min, max 10 hours 11 min). There was one intraoperative complication (bleeding from epigastric artery). The follow-up period ranged from 3 months to 3 years. There were no recurrent hernias. Postoperative complications were noted in 2 cases. One patient was diagnosed with epididymitis after TAPP, 1 patient - with seroma after eTEP-RS procedure. All complications were relieved by conservative treatment. Bleeding from a. epigastrica inferior was diagnosed after removal of the trocar at the end of surgery. This event required suturing.</p><p><strong>Conclusion: </strong>Robotic hernia repair appears to be technically feasible and safe. This approach provides favorable results regarding quality of life and recurrence rate.</p>","PeriodicalId":35986,"journal":{"name":"Khirurgiya","volume":" 3","pages":"14-20"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140111738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Hiatal hernia after esophagectomy]. [食管切除术后的食管裂孔疝]。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/hirurgia202411124
A B Ryabov, O V Pikin, V M Khomyakov, I V Kolobaev, N M Abdulkhakimov

Objective: To analyze the causes and surgical treatment of hiatal hernia after esophagectomy, technical features of surgery and methods of prevention.

Material and methods: We retrospectively analyzed the incidence of postoperative hiatal hernias after esophagectomy in patients with esophageal cancer between 2018 and 2023. Structure of hernias, surgical options and postoperative results were assessed.

Results: We analyzed 161 patients after Ivor Lewis (n=101) and McKeown (n=60) esophagectomies (open surge surgeries - 43.5%, thoraco- and laparoscopic procedures - 23%, hybrid procedures - 33.5%). The incidence of postoperative hiatal hernia was 3.7%. Hernia occurred within 1-15 months. There were 5 men and 1 woman (mean age 65 years). In all cases, partial or complete dissection of the left diaphragmatic crura was performed. The incidence of hernia after minimally invasive surgery was 4.4%, after open surgery - 2.9%. Two (33.3%) patients underwent urgent surgery for ileus within 2 months after primary esophageal surgery. Three (50%) patients underwent elective surgery. One (16.6%) patient is currently followed-up. The complication was asymptomatic in 2 (33.3%) patients. One (16.6%) patient died after emergency surgery in a COVID hospital due to strangulated hernia and progressive respiratory failure. Mean follow-up period was 16 months. No recurrent hernias were diagnosed.

Conclusion: Hiatal hernias occur 2 times more often after minimally invasive esophagectomies. Active surgical strategy is necessary for symptomatic hernias due to high risk of strangulation and emergency interventions. The incidence of this complication is lower without wide diaphragmotomy, transection of the left diaphragmatic crus and high abdominal pressure during laparoscopic stage.

摘要分析食管癌切除术后食管裂孔疝的病因、手术治疗方法、手术技术特点及预防方法:我们回顾性分析了2018年至2023年间食管癌患者食管切除术后食管裂孔疝的发生率。对疝的结构、手术方案和术后效果进行了评估:我们分析了 161 名接受 Ivor Lewis(n=101)和 McKeown(n=60)食管切除术的患者(开刀手术 - 43.5%,胸腔镜和腹腔镜手术 - 23%,混合手术 - 33.5%)。术后食管裂孔疝的发生率为3.7%。疝气发生在1-15个月内。患者中有 5 名男性和 1 名女性(平均年龄 65 岁)。所有病例都对左侧膈嵴进行了部分或完全剥离。微创手术后疝气发生率为4.4%,开放手术后为2.9%。有两名(33.3%)患者在食管原发性手术后两个月内因回肠瘘接受了紧急手术。三名患者(50%)接受了选择性手术。一名患者(16.6%)目前正在接受随访。2例(33.3%)患者的并发症无症状。一名患者(16.6%)在COVID医院接受急诊手术后因绞窄性疝气和进行性呼吸衰竭而死亡。平均随访时间为 16 个月。结论:贲门疝发生率为 2.2%:结论:微创食管切除术后发生食管裂孔疝的几率是微创食管切除术的 2 倍。结论:微创食管切除术后发生食管裂孔疝的几率是微创食管切除术后的 2 倍。由于绞窄和紧急干预的风险很高,有症状的疝气必须采取积极的手术策略。在腹腔镜手术阶段,如果没有进行宽膈肌切开术、横断左侧膈肌皱襞和高腹压,这种并发症的发生率较低。
{"title":"[Hiatal hernia after esophagectomy].","authors":"A B Ryabov, O V Pikin, V M Khomyakov, I V Kolobaev, N M Abdulkhakimov","doi":"10.17116/hirurgia202411124","DOIUrl":"https://doi.org/10.17116/hirurgia202411124","url":null,"abstract":"<p><strong>Objective: </strong>To analyze the causes and surgical treatment of hiatal hernia after esophagectomy, technical features of surgery and methods of prevention.</p><p><strong>Material and methods: </strong>We retrospectively analyzed the incidence of postoperative hiatal hernias after esophagectomy in patients with esophageal cancer between 2018 and 2023. Structure of hernias, surgical options and postoperative results were assessed.</p><p><strong>Results: </strong>We analyzed 161 patients after Ivor Lewis (<i>n</i>=101) and McKeown (<i>n</i>=60) esophagectomies (open surge surgeries - 43.5%, thoraco- and laparoscopic procedures - 23%, hybrid procedures - 33.5%). The incidence of postoperative hiatal hernia was 3.7%. Hernia occurred within 1-15 months. There were 5 men and 1 woman (mean age 65 years). In all cases, partial or complete dissection of the left diaphragmatic crura was performed. The incidence of hernia after minimally invasive surgery was 4.4%, after open surgery - 2.9%. Two (33.3%) patients underwent urgent surgery for ileus within 2 months after primary esophageal surgery. Three (50%) patients underwent elective surgery. One (16.6%) patient is currently followed-up. The complication was asymptomatic in 2 (33.3%) patients. One (16.6%) patient died after emergency surgery in a COVID hospital due to strangulated hernia and progressive respiratory failure. Mean follow-up period was 16 months. No recurrent hernias were diagnosed.</p><p><strong>Conclusion: </strong>Hiatal hernias occur 2 times more often after minimally invasive esophagectomies. Active surgical strategy is necessary for symptomatic hernias due to high risk of strangulation and emergency interventions. The incidence of this complication is lower without wide diaphragmotomy, transection of the left diaphragmatic crus and high abdominal pressure during laparoscopic stage.</p>","PeriodicalId":35986,"journal":{"name":"Khirurgiya","volume":" 11","pages":"24-29"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142711465","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Local anesthesia in percutaneous nephrostomy and trocar epicystostomy]. [经皮肾造瘘术和套管肾盂造瘘术中的局部麻醉]
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/hirurgia202411165
I V Feofilov

Introduction: In some cases, percutaneous nephrostomy (PNS) and trocar epicystostomy (TCS), which require adequate anesthesia, are used to restore the passage of urine. The choice of method, namely general or local anesthesia, depends on many factors, including the risks and complications of anesthetic care and should be made individually.

Objective: To analyze the efficacy and safety of local anesthesia using articaine in PNS and TCS.

Materials and methods: The study included 85 patients aged 40-60 years who had undergone PNS or TCS. Positive allergic background, significant comorbidity, severe obesity, cicatrical changes in the area of operation were the exclusion criteria. Patients were divided into two groups depending on the type of anesthetic for local anesthesia. Specifically, 2% Articaine-Binergia - 2 ml diluted in 10 ml of 0.9% saline solution was used in the first group of 48 (40 PNS and 8 TCS) humans, and 2% Lidocaine - 2 ml in the same dilution was used in the second group of 37 (30 PNS and 7 TCS) subjects.

Results: The articaine group has been considerably superior to the lidocaine one on all indicators in the clinical evaluation of anesthesia's efficacy in scores. A better safety profile has been noted by symptoms of allergic reaction, tissue neurotoxicity, formation of hematomas and infiltration of the injection site in the analysis of adverse events (complications) in the articaine group.

Conclusions: The conducted study on the use of Articaine-Binergia in urological interventions requiring local anesthesia, in particular such as PNS and TCS, showed that Articaine-Binergia exceeded lidocaine in analgesic effect and safety profile, and, importantly, saving in anesthetic's use due to the lower total volume of administration has been noted.

导言:在某些情况下,需要进行充分麻醉的经皮肾造瘘术(PNS)和套管肾盂造口术(TCS)可用于恢复尿液通过。选择何种方法,即全身麻醉还是局部麻醉,取决于很多因素,包括麻醉护理的风险和并发症,应根据具体情况而定:分析在 PNS 和 TCS 中使用阿替卡因进行局部麻醉的有效性和安全性:研究纳入了 85 名年龄在 40-60 岁之间、接受过 PNS 或 TCS 的患者。阳性过敏背景、严重合并症、严重肥胖、手术区域有糜烂性病变是排除标准。根据局部麻醉的麻醉剂类型,患者被分为两组。具体来说,第一组 48 人(40 名 PNS 和 8 名 TCS)使用 2% 阿替卡因-宾格亚 - 2 毫升稀释在 10 毫升 0.9% 生理盐水中,第二组 37 人(30 名 PNS 和 7 名 TCS)使用相同稀释度的 2% 利多卡因 - 2 毫升:结果:在麻醉效果的临床评估评分中,阿替卡因组在所有指标上都明显优于利多卡因组。在不良事件(并发症)的分析中,阿替卡因组的过敏反应症状、组织神经毒性、血肿形成和注射部位浸润的安全性更好:关于在需要局部麻醉的泌尿外科手术中使用阿替卡因-宾格亚的研究表明,阿替卡因-宾格亚在镇痛效果和安全性方面均优于利多卡因。
{"title":"[Local anesthesia in percutaneous nephrostomy and trocar epicystostomy].","authors":"I V Feofilov","doi":"10.17116/hirurgia202411165","DOIUrl":"https://doi.org/10.17116/hirurgia202411165","url":null,"abstract":"<p><strong>Introduction: </strong>In some cases, percutaneous nephrostomy (PNS) and trocar epicystostomy (TCS), which require adequate anesthesia, are used to restore the passage of urine. The choice of method, namely general or local anesthesia, depends on many factors, including the risks and complications of anesthetic care and should be made individually.</p><p><strong>Objective: </strong>To analyze the efficacy and safety of local anesthesia using articaine in PNS and TCS.</p><p><strong>Materials and methods: </strong>The study included 85 patients aged 40-60 years who had undergone PNS or TCS. Positive allergic background, significant comorbidity, severe obesity, cicatrical changes in the area of operation were the exclusion criteria. Patients were divided into two groups depending on the type of anesthetic for local anesthesia. Specifically, 2% Articaine-Binergia - 2 ml diluted in 10 ml of 0.9% saline solution was used in the first group of 48 (40 PNS and 8 TCS) humans, and 2% Lidocaine - 2 ml in the same dilution was used in the second group of 37 (30 PNS and 7 TCS) subjects.</p><p><strong>Results: </strong>The articaine group has been considerably superior to the lidocaine one on all indicators in the clinical evaluation of anesthesia's efficacy in scores. A better safety profile has been noted by symptoms of allergic reaction, tissue neurotoxicity, formation of hematomas and infiltration of the injection site in the analysis of adverse events (complications) in the articaine group.</p><p><strong>Conclusions: </strong>The conducted study on the use of Articaine-Binergia in urological interventions requiring local anesthesia, in particular such as PNS and TCS, showed that Articaine-Binergia exceeded lidocaine in analgesic effect and safety profile, and, importantly, saving in anesthetic's use due to the lower total volume of administration has been noted.</p>","PeriodicalId":35986,"journal":{"name":"Khirurgiya","volume":" 11","pages":"65-70"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142711470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Evolution of systemic and local hemostatic agents in armed conflicts]. [武装冲突中全身和局部止血剂的演变]。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/hirurgia202411194
I D Gretsov, M A Dmitriev, E G Obedkov, I S Ivanov

The issue of emergency care for traumatic bleeding is of particular relevance in modern medicine due to widespread military conflicts. This characterizes the need to summarize available data on hemostatic agents in combat conditions. This review of available literature is devoted to systemic and local hemostatic agents, as well as devices for temporary bleeding arrest. The most promising local hemostatic agents are chitosan-based products. Systemic hemostatic agents are represented by various forms and require further clinical trials. Modern tourniquets significantly reduce the mortality rate in extreme conditions and significantly exceed their historical counterparts in convenience and efficiency.

由于军事冲突频发,创伤性出血的紧急救治问题在现代医学中尤为重要。因此,有必要总结有关战斗条件下止血剂的现有数据。本篇文献综述主要涉及全身和局部止血剂,以及用于暂时止血的设备。最有前途的局部止血剂是以壳聚糖为基础的产品。全身止血剂有多种形式,需要进一步的临床试验。现代止血带大大降低了极端条件下的死亡率,在方便性和效率方面也大大超过了历史上的同类产品。
{"title":"[Evolution of systemic and local hemostatic agents in armed conflicts].","authors":"I D Gretsov, M A Dmitriev, E G Obedkov, I S Ivanov","doi":"10.17116/hirurgia202411194","DOIUrl":"https://doi.org/10.17116/hirurgia202411194","url":null,"abstract":"<p><p>The issue of emergency care for traumatic bleeding is of particular relevance in modern medicine due to widespread military conflicts. This characterizes the need to summarize available data on hemostatic agents in combat conditions. This review of available literature is devoted to systemic and local hemostatic agents, as well as devices for temporary bleeding arrest. The most promising local hemostatic agents are chitosan-based products. Systemic hemostatic agents are represented by various forms and require further clinical trials. Modern tourniquets significantly reduce the mortality rate in extreme conditions and significantly exceed their historical counterparts in convenience and efficiency.</p>","PeriodicalId":35986,"journal":{"name":"Khirurgiya","volume":" 11","pages":"94-99"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142711463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Interventional radiological and endoscopic technologies in diagnosis and treatment of chronic pancreatitis]. [诊断和治疗慢性胰腺炎的介入放射学和内窥镜技术]。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/hirurgia202411184
A N Akinchits, E I Abramyan, A V Kitaeva, I V Mikhin, O Vorontsov

This review is devoted to internationally accepted diagnostic algorithms for complicated chronic pancreatitis (CP). In addition, the authors discuss interventional radiological and endoscopic diagnostic and therapeutic procedures, as well as their role in surgical approaches for this disease. Chronic pancreatitis is often diagnosed with severe symptoms following severe course of disease and complications. Imaging techniques, such as ultrasound, endoscopic ultrasound, CT, MRI/MR cholangiocreatography (MRCP), secretin-stimulated MRCP, are valuable to assess the pancreas in patients with initial manifestations of CP. Modern treatment of complicated CP includes transpapillary or transmural drainage of false cysts, shock wave lithotripsy and stenting for pancreatic duct strictures and/or stones, stenting for biliary hypertension, endovascular interventions for vascular complications and radical surgical treatment. Endoscopic methods are preferable regarding better short-term quality of life. Early surgical intervention (within 3 years after clinical manifestation) is effective to eliminate or significantly reduce pain and pancreatic insufficiency. Multidisciplinary team including surgeons, endoscopists and interventional radiologists should determine the most optimal diagnostic and treatment approach individually for each patient.

这篇综述介绍了国际公认的复杂性慢性胰腺炎(CP)诊断算法。此外,作者还讨论了介入放射学和内窥镜诊断与治疗程序,以及它们在该疾病的手术治疗中的作用。慢性胰腺炎通常在病程和并发症严重后出现严重症状时被诊断出来。超声波、内窥镜超声波、CT、MRI/MR 胆管造影(MRCP)、胰泌素刺激 MRCP 等影像学技术对于评估 CP 初期表现患者的胰腺非常有价值。复杂性 CP 的现代治疗包括假性囊肿的经毛细血管或经壁引流术、胰管狭窄和/或结石的冲击波碎石术和支架术、胆道高压的支架术、血管并发症的血管内介入治疗以及根治性手术治疗。就短期生活质量而言,内窥镜方法更可取。早期手术干预(临床表现后 3 年内)可有效消除或显著减轻疼痛和胰腺功能不全。包括外科医生、内镜医生和介入放射科医生在内的多学科团队应根据每位患者的具体情况确定最佳的诊断和治疗方法。
{"title":"[Interventional radiological and endoscopic technologies in diagnosis and treatment of chronic pancreatitis].","authors":"A N Akinchits, E I Abramyan, A V Kitaeva, I V Mikhin, O Vorontsov","doi":"10.17116/hirurgia202411184","DOIUrl":"https://doi.org/10.17116/hirurgia202411184","url":null,"abstract":"<p><p>This review is devoted to internationally accepted diagnostic algorithms for complicated chronic pancreatitis (CP). In addition, the authors discuss interventional radiological and endoscopic diagnostic and therapeutic procedures, as well as their role in surgical approaches for this disease. Chronic pancreatitis is often diagnosed with severe symptoms following severe course of disease and complications. Imaging techniques, such as ultrasound, endoscopic ultrasound, CT, MRI/MR cholangiocreatography (MRCP), secretin-stimulated MRCP, are valuable to assess the pancreas in patients with initial manifestations of CP. Modern treatment of complicated CP includes transpapillary or transmural drainage of false cysts, shock wave lithotripsy and stenting for pancreatic duct strictures and/or stones, stenting for biliary hypertension, endovascular interventions for vascular complications and radical surgical treatment. Endoscopic methods are preferable regarding better short-term quality of life. Early surgical intervention (within 3 years after clinical manifestation) is effective to eliminate or significantly reduce pain and pancreatic insufficiency. Multidisciplinary team including surgeons, endoscopists and interventional radiologists should determine the most optimal diagnostic and treatment approach individually for each patient.</p>","PeriodicalId":35986,"journal":{"name":"Khirurgiya","volume":" 11","pages":"84-93"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142711469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Experimental studies of biodegradable ureteral stent prototype].
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/hirurgia2024122117
N G Sedush, E A Anokhin, S N Chvalun, A V Semin, V V Korolev, K V Kotenko, I I Eremin, S V Korolev

Degradable ureteral stent not requiring redo procedure for removal is an important issue in modern urology. This device could solve the problem of «forgotten stent» often leading to long-term complications. The authors describe the prototype of biodegradable ureteral stent based on poly(L-lactide-co-ε-caprolactone) and present the first results of its testing. Characteristics of synthesized polymer meet the requirements in medicine. Tests of rod-shaped stent prototypes showed that material has sufficient strength and elasticity. Analysis of stent degradation in artificial urine environment at 37 ºC showed that it retains strength for at least 2 weeks. No suppression of cell growth confirms no cellular toxicity. New material based on poly(L-lactide-co-ε-caprolactone) is promising for development of experimental samples of biodegradable ureteral stents and further in vivo testing.

{"title":"[Experimental studies of biodegradable ureteral stent prototype].","authors":"N G Sedush, E A Anokhin, S N Chvalun, A V Semin, V V Korolev, K V Kotenko, I I Eremin, S V Korolev","doi":"10.17116/hirurgia2024122117","DOIUrl":"https://doi.org/10.17116/hirurgia2024122117","url":null,"abstract":"<p><p>Degradable ureteral stent not requiring redo procedure for removal is an important issue in modern urology. This device could solve the problem of «forgotten stent» often leading to long-term complications. The authors describe the prototype of biodegradable ureteral stent based on poly(L-lactide-co-ε-caprolactone) and present the first results of its testing. Characteristics of synthesized polymer meet the requirements in medicine. Tests of rod-shaped stent prototypes showed that material has sufficient strength and elasticity. Analysis of stent degradation in artificial urine environment at 37 ºC showed that it retains strength for at least 2 weeks. No suppression of cell growth confirms no cellular toxicity. New material based on poly(L-lactide-co-ε-caprolactone) is promising for development of experimental samples of biodegradable ureteral stents and further <i>in vivo</i> testing.</p>","PeriodicalId":35986,"journal":{"name":"Khirurgiya","volume":" 12. Vyp. 2","pages":"117-121"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142814313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Assessment of real myocardial energy demand using indirect calorimetry in early postoperative period after cardiac surgery].
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.17116/hirurgia202412250
L S Sorokina, S S Yudina, A S Petrov, S V Fedulova, A V Novikova, A V Goncharova, A A Eremenko

Objective: To evaluate actual myocardial energy requirements using indirect calorimetry, oxygen delivery (DO2), oxygen extraction ratio (O2ER), cardiac output (CO) and their components, as well as to study the impact of positive inotropic agent (dobutamine) on myocardial metabolism in early postoperative period after cardiac surgery.

Material and methods: We measured the main metabolic parameters using indirect calorimetry in 20 patients after on-pump cardiac surgery with cardioplegia. To evaluate the impact of metabolic load on CO, VO2 and DO2, we administered dobutamine 3 µg/kg/min at the second phase of the study. Basal metabolic parameters were recorded together with CO and arterial and venous blood gas composition.

Results: Under dobutamine infusion, VO2I and VCO2 significantly increased by 10%, DO2I increased by 27%, and O2ER decreased by 10%. Aerobic metabolism increased from 1902.3±380.6 to 2130.9±423.1 kcal/day. The predicted energy expenditure values (Harris-Benedict equation) were significantly lower (1759.7±255.6 kcal/day). Cardiac index increased by 26%, stroke volume - by 10%, heart rate - by 21%. Central venous pressure, left ventricular end-diastolic volume and ejection fraction were the same. VO2I obtained through indirect calorimetry were higher than those measured using the reverse Fick method. At the first phase, these values were 138.6±28.9 and 72.8±27.6 ml/min/m², at the second phase - 155.4±28.2 and 68.1±27.1 ml/min/m², respectively.

Conclusion: Energy expenditure exceeded the predicted values. This was accompanied by elevated VO2 and DO2 with moderate decrease of O2ER in postoperative period. VO2 values assessed by indirect calorimetry and reverse Fick method represent two distinct physiological parameters, and they are not interchangeable. Further studies are required to assess this technology in critically ill patients.

{"title":"[Assessment of real myocardial energy demand using indirect calorimetry in early postoperative period after cardiac surgery].","authors":"L S Sorokina, S S Yudina, A S Petrov, S V Fedulova, A V Novikova, A V Goncharova, A A Eremenko","doi":"10.17116/hirurgia202412250","DOIUrl":"https://doi.org/10.17116/hirurgia202412250","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate actual myocardial energy requirements using indirect calorimetry, oxygen delivery (DO<sub>2</sub>), oxygen extraction ratio (O<sub>2</sub>ER), cardiac output (CO) and their components, as well as to study the impact of positive inotropic agent (dobutamine) on myocardial metabolism in early postoperative period after cardiac surgery.</p><p><strong>Material and methods: </strong>We measured the main metabolic parameters using indirect calorimetry in 20 patients after on-pump cardiac surgery with cardioplegia. To evaluate the impact of metabolic load on CO, VO<sub>2</sub> and DO<sub>2</sub>, we administered dobutamine 3 µg/kg/min at the second phase of the study. Basal metabolic parameters were recorded together with CO and arterial and venous blood gas composition.</p><p><strong>Results: </strong>Under dobutamine infusion, VO<sub>2</sub>I and VCO<sub>2</sub> significantly increased by 10%, DO<sub>2</sub>I increased by 27%, and O<sub>2</sub>ER decreased by 10%. Aerobic metabolism increased from 1902.3±380.6 to 2130.9±423.1 kcal/day. The predicted energy expenditure values (Harris-Benedict equation) were significantly lower (1759.7±255.6 kcal/day). Cardiac index increased by 26%, stroke volume - by 10%, heart rate - by 21%. Central venous pressure, left ventricular end-diastolic volume and ejection fraction were the same. VO<sub>2</sub>I obtained through indirect calorimetry were higher than those measured using the reverse Fick method. At the first phase, these values were 138.6±28.9 and 72.8±27.6 ml/min/m², at the second phase - 155.4±28.2 and 68.1±27.1 ml/min/m², respectively.</p><p><strong>Conclusion: </strong>Energy expenditure exceeded the predicted values. This was accompanied by elevated VO<sub>2</sub> and DO<sub>2</sub> with moderate decrease of O<sub>2</sub>ER in postoperative period. VO<sub>2</sub> values assessed by indirect calorimetry and reverse Fick method represent two distinct physiological parameters, and they are not interchangeable. Further studies are required to assess this technology in critically ill patients.</p>","PeriodicalId":35986,"journal":{"name":"Khirurgiya","volume":" 12. Vyp. 2","pages":"50-57"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142814354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Khirurgiya
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1